You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

CLINICAL TRIALS PROFILE FOR TOPROL-XL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Toprol-xl

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00038077 ↗ Reversal of Ventricular Remodeling With Toprol-XL Completed AstraZeneca Phase 3 2001-08-01 The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease.
NCT00123903 ↗ COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria Terminated GlaxoSmithKline Phase 3 2005-07-01 This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.
NCT00241904 ↗ Reducing Total Cardiovascular Risk in an Urban Community Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 4 2006-05-01 PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
NCT00241904 ↗ Reducing Total Cardiovascular Risk in an Urban Community Completed Johns Hopkins University Phase 4 2006-05-01 PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Toprol-xl

Condition Name

Condition Name for Toprol-xl
Intervention Trials
Hypertension 8
Diabetes Mellitus 2
Fasting 2
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Toprol-xl
Intervention Trials
Hypertension 10
Heart Failure 4
Diabetes Mellitus 2
Atrial Fibrillation 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Toprol-xl

Trials by Country

Trials by Country for Toprol-xl
Location Trials
United States 162
Canada 17
India 5
Puerto Rico 2
Dominican Republic 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Toprol-xl
Location Trials
New York 8
Pennsylvania 8
Ohio 8
Florida 8
California 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Toprol-xl

Clinical Trial Phase

Clinical Trial Phase for Toprol-xl
Clinical Trial Phase Trials
Phase 4 5
Phase 3 7
Phase 2 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Toprol-xl
Clinical Trial Phase Trials
Completed 17
Terminated 3
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Toprol-xl

Sponsor Name

Sponsor Name for Toprol-xl
Sponsor Trials
AstraZeneca 4
IPCA Laboratories Ltd. 3
Dr. Reddy's Laboratories Limited 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Toprol-xl
Sponsor Trials
Industry 20
Other 11
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.